CD226 and Miyoshi myopathy: In a murine model of MM relapse after stem cell transplant, mice showed effector CD8+T cells with exhausted features, namely high TIGIT expression and low CD226 expression, and the anti-TIGIT treatment was able to improve disease control rates [21].